rheumatologyadvisor.com
Large Vessel Vasculitis in IBD Linked to Younger Onset, Distinct Clinical Features
This study suggests LVV can occur in people with IBD at younger ages and with distinct vascular findings, and it may arise even when gut disease is in remission. That matters for awareness, diagnosis, and coordination between gastroenterology and rheumatology teams.
Adults with IBD (Crohn disease or UC), gastroenterologists, rheumatologists, and clinicians managing immunosuppression or biologic therapy.
What To Know
Patients with IBD who develop large-vessel vasculitis (LVV) — including Takayasu arteritis (TA) and giant cell arteritis (GCA) — appear to have earlier LVV onset and some different clinical features versus people with isolated LVV.
The study was a retrospective, multicenter case-control analysis of European patients (51 with both LVV and IBD vs 145 with isolated LVV). Compared with isolated disease, TA+IBD patients were younger at LVV diagnosis and had more severe vascular involvement (for example, higher rates of upper-limb claudication and increased inflammatory markers).
GCA+IBD patients were also younger and had more frequent arterial thickening/stenosis and more gastrointestinal artery involvement. Most LVV cases occurred after IBD diagnosis; many patients were in IBD remission when LVV appeared.
Treatments reported included systemic glucocorticoids and immunosuppressants, and a minority of LVV cases occurred while patients were receiving anti-TNF therapy. The study did not find a higher overall risk of LVV relapse linked to IBD, though ascending aorta involvement predicted relapse risk in TA.
The authors note limitations including the retrospective design, possible selection bias, and heterogeneity between European cases and French controls.
Findings come from a retrospective case-control study and do not prove causation. Treatment details and reasons for stopping anti-TNF in some cases were observational; clinicians should interpret these results in the context of individual patient situations and existing guidelines. The original Rheumatology article is the primary source for full methods and data.
